about
Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseasesUlcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association studySpecific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestineThe interplay between the microbiome and the adaptive immune response in cancer developmentIntestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease PathogenesisHelicobacter pylori vaccination: is there a path to protection?The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancerCritical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosisA Dormant Microbial Component in the Development of PreeclampsiaAntibiotics, pediatric dysbiosis, and diseaseInduction of intestinal Th17 cells by segmented filamentous bacteriaProtective and pro-inflammatory roles of intestinal bacteriaIn vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammationInhaled innate immune ligands to prevent pneumonia.Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum.Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection.The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Autoimmunity and the gutTh17 cytokines and the gut mucosal barrierLocal immunization impacts the response of dairy cows to Escherichia coli mastitis.Transcriptomic Analysis on Responses of Murine Lungs to Pasteurella multocida Infection.T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonizationThe impact of mucosal infections on acquisition and progression of tuberculosis.Perfluorooctane sulfonate affects intestinal immunity against bacterial infection.Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.Th17 cells and IL-17 in protective immunity to vaginal candidiasis.Mechanisms of neutrophil accumulation in the lungs against bacteria.Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity.Multispecies biofilms and host responses: "discriminating the trees from the forest".IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.Loss and dysregulation of Th17 cells during HIV infection.Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis.Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques.Role of interleukin-22 in inflammatory bowel diseaseImmune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis.IL-17 and Th17 cells in tuberculosisExtracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation
P2860
Q24607561-275B60B4-8E7F-4F0E-83C7-ADD4BBBCAC44Q24643514-B9E97AFB-2537-4821-A851-27FF1A938C11Q24648636-C00C71A0-9623-4FA9-A5ED-856B368EEF63Q26745703-A7F137BE-6399-4506-929C-D91C792F3C45Q26781239-21B544C8-BAE5-41E4-B0D9-4B39F37C6A80Q26865279-BEE57689-DA5A-484E-9AD4-6F9BE0140DAEQ27004062-ADD8270E-4790-40A0-8B47-927D463AB96EQ27334479-282A6031-6D70-477A-B4A4-CC5E0C9F554DQ28069689-8D73FF0E-3086-4998-B6A9-731852DCD89AQ28080536-1DA83599-9169-42CE-B018-D689BFB0F8D8Q28131638-5B6C696D-0F7A-463E-A945-96448985314AQ28273923-C551D443-D638-40F8-B772-19B816FE1285Q30371862-858A07D5-D4E3-402A-BCA5-FEE15368950BQ30398752-6AD8392E-6252-4315-B56A-ADAB652D4237Q33575993-BC3C0D10-532C-46EA-A4F3-DFDE73B4D509Q33606828-DE7C9135-34E0-4BC9-9B68-DFB25D34B98FQ33613877-7B485AC0-DE54-40AE-8A40-858A909D7619Q33639134-3EE6F83D-8EEC-415B-9398-6028E9802B60Q33676951-98994789-2675-4B34-BF98-D6B4C17233D6Q33743570-904B489B-7432-4113-8A5B-139C41E22D46Q33794078-18C43139-EF1F-42F1-B57C-F0C8E1A96318Q33813222-32CE4D65-2E69-4CAE-8969-FFC44EE6CCD2Q33820413-C10282A4-238A-4EC3-AD2B-6981F1A0D5FBQ33824260-756828A2-923B-4FCF-AF45-DC8AC7427D30Q33899365-CE258D65-B2F5-4ABF-BE28-797E6A59C118Q33935005-0FD12C6E-4CA7-4C37-A438-CFDC2B63FFCAQ33954291-AA6EE91A-2398-4FCE-A7F7-C38AA9652B8CQ33983438-9E385843-C00E-431C-B911-99CBE3D6202AQ34026316-FCF35D78-CD24-432A-AB28-1FE31A0AB2F8Q34037796-7AAB2B92-9C91-459B-BBBE-7AF9BDD0949FQ34040254-1C34391B-FB62-45E4-AC09-0CCBC986DAFCQ34112781-3EE3F093-BC9D-4E6F-9523-784E64C76298Q34350569-96F352AB-6A08-4D79-AB81-7F9A7BFB0155Q34358363-22AE8E8A-43B6-4715-B550-72613DAA2406Q34432491-5F15DD61-D056-4716-85BB-65F5910A5B9BQ34456769-9C14EA33-0FA8-450A-918C-89CE46360622Q34536026-57B0EC18-3863-48A2-8B0D-13A7C57C72BAQ34545889-F4C086B2-E24F-413C-90FD-67863E534B71Q34575695-C04EA4E6-E242-4FB1-B5DF-219638DBD918Q34649064-FB62B972-6954-4FAF-9358-CA34019E4FAC
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Th17 cells and mucosal host defense.
@ast
Th17 cells and mucosal host defense.
@en
type
label
Th17 cells and mucosal host defense.
@ast
Th17 cells and mucosal host defense.
@en
prefLabel
Th17 cells and mucosal host defense.
@ast
Th17 cells and mucosal host defense.
@en
P2093
P2860
P1476
Th17 cells and mucosal host defense.
@en
P2093
Jay K Kolls
Patricia J Dubin
Shean J Aujla
P2860
P304
P356
10.1016/J.SMIM.2007.10.009
P577
2007-11-28T00:00:00Z